期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 5, 页码 1911-1918出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI66024
关键词
-
资金
- Ministry of Education, Culture, Sports, Science and Technology
- National Cancer Center Research and Development Fund of Japan
- Intramural Research Program of the Center for Cancer Research, US National Cancer Institute [Z01 BC010876]
Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor markers are useful for isolating a subset of liver cells with stem cell features, known as cancer stem cells (CSCs). These cells are responsible for tumor relapse, metastasis, and chemoresistance. Liver CSCs dictate a hierarchical organization that is shared in both organogenesis and tumorigenesis. An increased understanding of the molecular signaling events that regulate cellular hierarchy and sternness, and success in defining key CSC-specific genes, have opened up new avenues to accelerate the development of novel diagnostic and treatment strategies. This Review highlights recent advances in understanding the pathogenesis of liver CSCs and discusses unanswered questions about the concept of liver CSCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据